Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             35 results found
no title author magazine year volume issue page(s) type
1 A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses Hurt, Aeron C
 2004
 103 1-2 p. 79-83
5 p.
 article
2 Are influenza surveillance data useful for mapping presentations? Uphoff, H
 2004
 103 1-2 p. 35-46
12 p.
 article
3 A “universal” human influenza A vaccine Fiers, W
 2004
 103 1-2 p. 173-176
4 p.
 article
4 Current status of live attenuated influenza virus vaccine in the US Belshe, Robert B
 2004
 103 1-2 p. 177-185
9 p.
 article
5 Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine Stephenson, I
 2004
 103 1-2 p. 91-95
5 p.
 article
6 Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation Cheng, Sheau-Mei
 2004
 103 1-2 p. 85-90
6 p.
 article
7 Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments Wit, Emmie de
 2004
 103 1-2 p. 155-161
7 p.
 article
8 Epidemiological features of a new strain of the influenza A virus—influenza A (H1N2) circulating in England and its public health implications Goddard, N.L
 2004
 103 1-2 p. 53-54
2 p.
 article
9 Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity Chen, Dexiang
 2004
 103 1-2 p. 147-153
7 p.
 article
10 Exploring cross-protection between influenza strains by an epidemiological model Lavenu, Audrey
 2004
 103 1-2 p. 101-105
5 p.
 article
11 Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs Reeth, Kristien Van
 2004
 103 1-2 p. 115-124
10 p.
 article
12 Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey Meerhoff, T.J
 2004
 103 1-2 p. 31-33
3 p.
 article
13 Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs Hurt, Aeron C
 2004
 103 1-2 p. 205-211
7 p.
 article
14 IFC (EDITORIAL BOARD) 2004
 103 1-2 p. IFC-
1 p.
 article
15 Immunogenicity and protective efficacy of influenza vaccination Hannoun, Claude
 2004
 103 1-2 p. 133-138
6 p.
 article
16 Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use Hehme, N
 2004
 103 1-2 p. 163-171
9 p.
 article
17 Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses Nichol, Kristin L
 2004
 103 1-2 p. 3-8
6 p.
 article
18 Influenza-associated acute encephalopathy in Japanese children in 1994–2002 Togashi, Takehiro
 2004
 103 1-2 p. 75-78
4 p.
 article
19 Live cold-adapted influenza A vaccine produced in Vero cell line Romanova, Julia
 2004
 103 1-2 p. 187-193
7 p.
 article
20 Medical economics in the field of influenza—past, present and future Szucs, Thomas D
 2004
 103 1-2 p. 25-30
6 p.
 article
21 Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply Medema, Jeroen K
 2004
 103 1-2 p. 9-15
7 p.
 article
22 Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors Gubareva, Larisa V
 2004
 103 1-2 p. 199-203
5 p.
 article
23 Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population Webby, R.J
 2004
 103 1-2 p. 67-73
7 p.
 article
24 Phylogenetic studies of influenza B viruses isolated in southern Africa: 1998–2001 Besselaar, Terry G
 2004
 103 1-2 p. 61-66
6 p.
 article
25 Preface Osterhaus, Albert
 2004
 103 1-2 p. 1-
1 p.
 article
26 Reassortment and evolution of current human influenza A and B viruses Xu, Xiyan
 2004
 103 1-2 p. 55-60
6 p.
 article
27 Recent changes among human influenza viruses Lin, Y.P
 2004
 103 1-2 p. 47-52
6 p.
 article
28 RETRACTED: The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses Seo, Sang Heui
 2004
 103 1-2 p. 107-113
7 p.
 article
29 Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes Rimmelzwaan, G.F
 2004
 103 1-2 p. 97-100
4 p.
 article
30 Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Beyer, W.E.P
 2004
 103 1-2 p. 125-132
8 p.
 article
31 Special Issue Contents Pages 2004
 103 1-2 p. vii-viii
nvt p.
 article
32 Special issue title page 2004
 103 1-2 p. v-
1 p.
 article
33 Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons Mungall, Bruce A
 2004
 103 1-2 p. 195-197
3 p.
 article
34 The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands van Genugten, Marianne L.L
 2004
 103 1-2 p. 17-23
7 p.
 article
35 Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers de Bruijn, I.A
 2004
 103 1-2 p. 139-145
7 p.
 article
                             35 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands